Evaluation of Perioperative Cystoscopy and Methylene Blue Test in Detecting Complications in TVT and TOT Procedures
Not Applicable
Recruiting
- Conditions
- Incontinence Stress
- Registration Number
- NCT06801938
- Lead Sponsor
- Gaziosmanpasa Research and Education Hospital
- Brief Summary
Comparison of complications detected by perioperative cystoscopy combined with methylene blue test and postoperative cystoscopy in TVT and TOT operations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 58
Inclusion Criteria
- Providing consent to participate in the study
- Being between the ages of 18 and 85
- Having stress urinary incontinence
- No active cardiac disease
- No connective tissue disorders (e.g., Marfan syndrome)
- No known gynecological malignancy
- BMI under 30
- No chronic constipation
- No inflammatory bowel disease
Exclusion Criteria
- Not providing consent to participate in the study
- Being under 18 or over 85 years old
- Not having stress urinary incontinence
- Having active cardiac disease
- Having connective tissue disorders (e.g., Marfan syndrome)
- Having a known gynecological malignancy
- Having a BMI over 30
- Having chronic constipation
- Having inflammatory bowel disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method rate of complication detection 6 months Specifically, it would compare the ability of the perioperative methylene blue test and cystoscopy versus postoperative cystoscopy to detect complications. This measure will be used to evaluate the accuracy and effectiveness of both methods
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does perioperative cystoscopy with methylene blue compare to postoperative cystoscopy in detecting TVT/TOT complications?
What molecular mechanisms underlie methylene blue's efficacy in detecting iatrogenic bladder injuries during TVT/TOT procedures?
Are there specific urodynamic biomarkers predicting higher complication risk in TVT or TOT procedures?
What adverse event profiles are associated with perioperative vs. postoperative cystoscopy in stress incontinence surgeries?
How does methylene blue use in TVT/TOT compare to other intraoperative bladder integrity tests like indigo carmine?
Trial Locations
- Locations (1)
Gaziosmanpaşa Training and Research Hospital
🇹🇷Istanbul, Turkey